Transcriptional regulation of the beta-synuclein 5′-promoter metal response element by metal transcription factor-1

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  McHugh, Patrick C ^a   Wright, Josephine A ^a   Brown, David R ^a  

^a University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SYNUCLEIN; COMPLEMENTARY DNA; MESSENGER RNA; METAL TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; METAL; TRANSCRIPTION FACTOR MTF 1; TRANSCRIPTION FACTOR MTF-1;

5' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BIOINFORMATICS; CONTROLLED STUDY; DNA FLANKING REGION; DOPAMINERGIC NERVE CELL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; CELL CULTURE; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

5' UNTRANSLATED REGIONS; BETA-SYNUCLEIN; BINDING SITES; CELLS, CULTURED; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMANS; METALS; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 79952257922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017354     Document Type: Article

References (51)

1. Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D, (2002) Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Radic Biol Med 32: 1076-83.
2. Uversky VN, Li J, Bower K, Fink AL, (2002) Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease. Neurotoxicology 23: 527-36.
3. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, et al. (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52: 1830-6.
4. Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, et al. (2003) Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J Biol Chem 278: 11753-9.
5. McNaught KS, Jenner P, (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett 297: 191-4.
6. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, et al. (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55: 174-9.
7. West AB, Zimprich A, Lockhart PJ, Farrer M, Singleton A, et al. (2001) Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes. Eur J Hum Genet 9: 659-66.
8. Nishioka K, Hayashi S, Farrer MJ, Singleton AB, Yoshino H, et al. (2006) Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann Neurol 59: 298-309.
9. Jakes R, Spillantini MG, Goedert M, (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345: 27-32.
10. Biere AL, Wood SJ, Wypych J, Steavenson S, Jiang Y, et al. (2000) Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs. J Biol Chem 275: 34574-9.
11. Ohtake H, Limprasert P, Fan Y, Onodera O, Kakita A, et al. (2004) Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology 63: 805-11.
12. Galvin JE, Uryu K, Lee VM, Trojanowski JQ, (1999) Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A 96: 13450-5.
13. Li W, Lesuisse C, Xu Y, Troncoso JC, Price DL, et al. (2004) Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation. J Neurosci 24: 7400-9.
14. Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, et al. (2001) Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res 914: 48-56.
15. Mori F, Nishie M, Yoshimoto M, Takahashi H, Wakabayashi K, (2003) Reciprocal accumulation of beta-synuclein in alpha-synuclein lesions in multiple system atrophy. Neuroreport 14: 1783-6.
16. Shen Q, Wang Y, Dimos JT, Fasano CA, Phoenix TN, et al. (2006) The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells. Nat Neurosci.
17. Kruger R, Vieira-Saecker AM, Kuhn W, Berg D, Muller T, et al. (1999) Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol 45: 611-7.
18. Xia Z, DePierre JW, Nassberger L, (1996) Dysregulation of bcl-2, c-myc, and Fas expression during tricyclic antidepressant-induced apoptosis in human peripheral lymphocytes. J Biochem Toxicol 11: 203-4.
19. Chiba-Falek O, Nussbaum RL, (2001) Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet 10: 3101-9.
20. McHugh PC, Rogers GR, Loudon B, Glubb DM, Joyce PR, et al. (2008) Proteomic analysis of embryonic stem cell-derived neural cells exposed to the antidepressant paroxetine. J Neurosci Res 86: 306-16.
21. Brown DR, (2004) Role of the prion protein in copper turnover in astrocytes. Neurobiol Dis 15: 534-43.
22. Wang X, Moualla D, Wright JA, Brown DR, (2010) Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity. J Neurochem 113: 704-14.
23. Lavedan C, Leroy E, Torres R, Dehejia A, Dutra A, et al. (1998) Genomic organization and expression of the human beta-synuclein gene (SNCB). Genomics 54: 173-5.
24. Schug J, (2008) Using TESS to predict transcription factor binding sites in DNA sequence. Curr Protoc Bioinformatics. Vol. Chapter 2pp. Unit 2.6. 2008.
25. Roth S, Zhang S, Chiu J, Wirth EK, Schweizer U, (2010) Development of a serum-free supplement for primary neuron culture reveals the interplay of selenium and vitamin E in neuronal survival. J Trace Elem Med Biol 24: 130-7.
26. Xie HR, Hu LS, Li GY, (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med J (Engl) 123: 1086-92.
27. Wright JA, Wang X, Brown DR, (2009) Unique copper-induced oligomers mediate alpha-synuclein toxicity. Faseb J 23: 2384-93.
28. LaRochelle O, Labbe S, Harrisson JF, Simard C, Tremblay V, et al. (2008) Nuclear factor-1 and metal transcription factor-1 synergistically activate the mouse metallothionein-1 gene in response to metal ions. J Biol Chem 283: 8190-201.
29. Heuchel R, Radtke F, Georgiev O, Stark G, Aguet M, et al. (1994) The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. Embo J 13: 2870-5.
30. Serfling E, Lubbe A, Dorsch-Hasler K, Schaffner W, (1985) Metal-dependent SV40 viruses containing inducible enhancers from the upstream region of metallothionein genes. Embo J 4: 3851-9.
31. Stuart GW, Searle PF, Palmiter RD, (1985) Identification of multiple metal regulatory elements in mouse metallothionein-I promoter by assaying synthetic sequences. Nature 317: 828-31.
32. Saydam N, Georgiev O, Nakano MY, Greber UF, Schaffner W, (2001) Nucleo-cytoplasmic trafficking of metal-regulatory transcription factor 1 is regulated by diverse stress signals. J Biol Chem 276: 25487-95.
33. Lichtlen P, Schaffner W, (2001) The metal transcription factor MTF-1: biological facts and medical implications. Swiss Med Wkly 131: 647-52.
34. Shinyashiki M, Chiang KT, Switzer CH, Gralla EB, Valentine JS, et al. (2000) The interaction of nitric oxide (NO) with the yeast transcription factor Ace1: A model system for NO-protein thiol interactions with implications to metal metabolism. Proc Natl Acad Sci U S A 97: 2491-6.
35. Uttara B, Singh AV, Zamboni P, Mahajan RT, (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7: 65-74.
36. Bolognin S, Messori L, Zatta P, (2009) Metal ion physiopathology in neurodegenerative disorders. Neuromolecular Med 11: 223-38.
37. Saini N, Schaffner W, (2010) Zinc supplement greatly improves the condition of parkin mutant Drosophila. Biol Chem 391: 513-8.
38. Bahadorani S, Mukai S, Egli D, Hilliker AJ, (2010) Overexpression of metal-responsive transcription factor (MTF-1) in Drosophila melanogaster ameliorates life-span reductions associated with oxidative stress and metal toxicity. Neurobiol Aging 31: 1215-26.
39. Binolfi A, Lamberto GR, Duran R, Quintanar L, Bertoncini CW, et al. (2008) Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation. J Am Chem Soc 130: 11801-12.
40. Davies P, Wang X, Sarell CJ, Drewett A, Marken F, et al. (2010) The Synucleins are a Family of Redox Active Copper Binding Proteins. Biochemistry DOI:10.1021/bi101582.
41. Uversky VN, Li J, Fink AL, (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 276: 44284-96.
42. Paik SR, Shin HJ, Lee JH, Chang CS, Kim J, (1999) Copper(II)-induced self-oligomerization of alpha-synuclein. Biochem J 340 (Pt 3): 821-8.
43. Lee JC, Gray HB, Winkler JR, (2008) Copper(II) binding to alpha-synuclein, the Parkinson's protein. J Am Chem Soc 130: 6898-9.
44. Fan Y, Limprasert P, Murray IV, Smith AC, Lee VM, et al. (2006) Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression. Hum Mol Genet 15: 3002-11.
45. Bellingham SA, Coleman LA, Masters CL, Camakaris J, Hill AF, (2009) Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1. J Biol Chem 284: 1291-301.
46. Anderson L, Seilhamer J, (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18: 533-7.
47. Pradet-Balade B, Boulme F, Mullner EW, Garcia-Sanz JA, (2001) Reliability of mRNA profiling: verification for samples with different complexities. Biotechniques 30: 1352-7.
48. Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E, (2001) beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 32: 213-23.
49. Park JY, Lansbury PT Jr, (2003) Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. Biochemistry 42: 3696-700.
50. Wright JA, McHugh PC, Stockbridge M, Lane S, Kralovicova S, et al. (2009) Activation and repression of prion protein expression by key regions of intron 1. Cell Mol Life Sci 66: 3809-20.
51. Wang X, Moualla D, Wright JA, Brown DR, (2010) Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity. J Neurochem 113: 704-14.